Biogen Inc. buy Royal Bank of Canada
Start price
07.04.26
/
50%
€149.80
Target price
07.04.27
€184.73
Performance (%)
1.09%
Price
07.04.26
€151.44
Summary
This prediction is currently active. With a performance of 1.09%, the BUY prediction by Royal_Bank_of_Canada for Biogen Inc. is trending in the right direction. This prediction currently runs until 07.04.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biogen Inc. | 1.09% |
| iShares Core DAX® | 0.231% |
| iShares Nasdaq 100 | 1.663% |
| iShares Nikkei 225® | -0.208% |
| iShares S&P 500 | 1.067% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (BIIB) had its price target lowered by Royal Bank Of Canada from $233.00 to $213.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat